期刊文献+

幽门螺杆菌感染的密度和在胃黏膜层不同深度的定植对其致病性和抗生素耐药的影响 被引量:6

Helicobacter pylori infection density and colonization depth in gastric mucosa: Influence on pathogenicity and drug resistance
下载PDF
导出
摘要 目的:观察幽门螺杆菌(Helicobacter pylori,H.pylori)在胃黏膜的感染密度及在胃黏膜层不同深度的分布定植对胃黏膜炎症的影响,探讨H.pylori生物膜在其致病性及对抗生素产生耐药机制中的作用.方法:组织病理学观察158例H.pylori阳性慢性胃炎或消化性溃疡患者的胃黏膜病变活检标本,应用苏木精-伊红染色对胃黏膜炎症程度及活动程度分级并观察H.pylori感染密度,比较两者的相关性.应用免疫组织化学染色观察H.pylori在黏膜表面、胃小凹及浅层腺体的分布,比较胃黏膜层不同深度H.pylori定植情况及其感染密度与炎症的关系.结果:免疫组织化学染色显示H.pylori定植在胃黏膜层表面、小凹及浅层腺体.158例胃黏膜组织,黏膜表面H.pylori(+)41例、(++)38例、(+++)79例;小凹(+)29例、(++)42例、(+++)74例;浅层腺体(+)51例、(++)51例、(+++)39例.胃黏膜表面及小凹H.pylori密度与黏膜炎症程度有相关性(P<0.05);浅层腺体H.pylori密度与黏膜炎症程度无明显相关性(P>0.05).158例胃黏膜组织,黏膜表面H.pylori(+)40例、(++)39例、(+++)79例;小凹(+)29例、(++)41例、(+++)74例;浅层腺体(+)48例、(++)53例、(+++)29例.胃黏膜层表面、小凹及浅层腺体H.pylori密度与胃黏膜炎症活动性均有相关性(P<0.05),H.pylori在胃黏膜层不同深度密度越高胃黏膜炎症活动程度越重.结论:H.pylori可以定植在胃黏膜层表面、小凹和浅层腺体,H.pylori感染密度与胃黏膜炎症程度有相关性.具有细菌数量(感染密度)依赖性的H.pylori生物膜可能参与了其致病性及对抗生素的耐药. AIM: To observe the influence of Helicobacter pylori(H. pylori) infection density and colonization depth in the gastric mucosa on the severity of gastric mucosal inflammation, in order to approach the pathogenicity and the mechanism of antibiotic resistance caused by the H. pylori biofilm.METHODS: Gastric mucosal biopsy specimens were histopathologically studied in 158 patients with H. pylori positive chronic gastritis and peptic ulcer. The severity of gastric mucosa inflammation and the H.pylori infection density were evaluated using haematoxylin-eosin staining to explore the relationship between H. pylori infection density and the severity of gastric mucosa inflammation. The colonization of H. pylori in different layers of the gastric mucosa(gastric mucosa surface, gastric pits, and superficial glands) was observed by immunohistochemistry. The relationship between the H. pylori colonization depth and the severity of gastric mucosa inflammation was analyzed statistically.RESULTS: H. pylori can colonize at the surface, pits and superficial glands of the gastric mucosa as revealed by immunohistochemistry. Of 158 gastric mucosa specimens, 41 had low H. pylori density(+) at the surface of the gastric mucosa, 38 had moderate H. pylori density(++), and 79 had high density(+++); the corresponding figures were 29, 42 and 74 at the pits, and 51, 51 and 39 at the superficial glands. There was a significant association between H. pylori density and the inflammatory severity at the surface and pits(P〈0.05), but not at the superficial glands(P〈0.05). Of 158 gastric mucosa specimens, 40 had low H. pylori density(+) at the surface of the gastric mucosa, 39 had moderate H. pylori density(++), and 79 had high density(+++); the corresponding figures were 29, 41 and 74 at the pits, and 48, 53 and 29 at the superficial glands. There were significant associations between H. pylori density and inflammatory activity at the surface, pits, and superficial glands(P〈0.05). Higher H. pylori density was associated with more severe mucosal inflammation.CONCLUSION: H. pylori can colonize at the surface, pits and superficial glands of the gastric mucosa layer. There is a significant association between H. pylori infection density and the severity of gastric mucosa inflammation. H. pylori biofilm, which is formed depending on bacterial number(infection density), may participate in the pathogenicity and antibiotics resistance of H. pylori.
出处 《世界华人消化杂志》 CAS 2016年第3期347-354,共8页 World Chinese Journal of Digestology
基金 海南省自然科学基金资助项目 No.811170~~
关键词 幽门螺杆菌 定植 感染密度 生物膜 致病性 抗生素耐药 Helicobacter pylori Colonization Infection density Biofilm Pathogenicity Antibiotics resistance
  • 相关文献

参考文献9

二级参考文献121

  • 1尹洪芳,李挺,张莹.胃肠B细胞淋巴瘤的增殖与凋亡及其与幽门螺杆菌的关系[J].北京大学学报(医学版),2004,36(4):348-352. 被引量:4
  • 2陈波曼,余加林.细菌生物膜形成和耐药机制研究进展[J].中国抗生素杂志,2005,30(10). 被引量:19
  • 3魏红,杨桂彬,胡伏莲.幽门螺杆菌毒素及其与临床疾病相关性的研究进展[J].中华医学杂志,2005,85(37):2659-2662. 被引量:13
  • 4成虹,胡伏莲.北京地区幽门螺杆菌耐药情况及其变化趋势[J].中华医学杂志,2005,85(39):2754-2757. 被引量:176
  • 5Kanbay M, Gtlr G, Yttcel M, et al. Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci, 2005, 50: 1228-1231.
  • 6w O'Connor A, Gisbert J, O'Morain C. Treatment of Helicobacter pylori infection. Helicobacter, 2009, 14 Suppl 1: 46-51.
  • 7Selgrad M, Malfertheiner P. Treatment of Helicobacter pylori. Curt Opin Gastroenterol, 2011, 27 : 565-570.
  • 8De Francesco V, Zullo A, Ierardi E, et al. Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome : benefits and limits. J Antimicrob Chemother, 2010, 65: 327-332.
  • 9Agudo S, Alarc6n T, Urruzuno P, et al. Detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies of pediatric patients by using a commercially available real-time polymerase chain reaction after NucliSens semiautomated DNA extraction. Diagn Microbial Infect Dis, 2010, 67: 213-219.
  • 10Liou JM, Chang CY, Sheng WH, et al. Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies. Antimicrob Agents Chemother, 2011, 55 : 1123-1129.

共引文献496

同被引文献76

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部